Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fusion protein composition(s) comprising masked type I interferons (IFNA and IFNB) for use in the treatment of cancer and methods thereof

Fusion protein composition(s) comprising masked type I interferons (IFNA and IFNB) for use in the treatment of cancer and methods thereof

US Patent 11795198 · Granted Oct 24, 2023

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibody-interferon fusion proteins for enhancing adoptive T cell therapies for 2025
Antibody-interferon fusion proteins for enhancing adoptive T cell therapies for 2025
Antibody-interferon fusion proteins for enhancing adoptive T cell therapies for 2025
Formulated and/or co-formulated liposome compositions containing toll-like recep2025
Formulated and/or co-formulated liposome compositions containing IDO antagonist 2025
Fusion protein composition(s) comprising masked type i interferons (IFNA and IFN2024
Fusion protein composition(s) comprising masked type i interferons (IFNA and IFN2024
Fusion protein composition(s) comprising masked type i interferons (IFNA and IFN2024
Fusion protein composition(s) comprising masked type i interferons (IFNA and IFN2024
Fusion protein composition(s) comprising masked type i interferons (IFNA and IFN2024
Formulated and/or co-formulated liposome compositions containing PD-1 antagonist2024
Formulated and/or co-formulated liposome compositions containing toll-like recep2024